Preventive healthcare

Japan Dental Insurance Market (2022-2027): Increased Cost of Dental Surgeries and Awareness of Oral Hygiene Pushing Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 28, 2022
Health, Professional Services, Dental, Insurance, Health Insurance, Minor, Demography, USD, Old age, Industry, Foodservice, Corporate bond, Food, Metal, CAGR, Refinery, Preventive healthcare, DHMO, DPPO, Health insurance, Others, Chemical substance, Mining

Japan's Dental Insurance Market is estimated to be USD 4.67 Bn in 2022 and is expected to reach USD 7.57 Bn by 2027, growing at a CAGR of 10.14%.

Key Points: 
  • Japan's Dental Insurance Market is estimated to be USD 4.67 Bn in 2022 and is expected to reach USD 7.57 Bn by 2027, growing at a CAGR of 10.14%.
  • A complete analysis of the market, including the parent industry
    Japan's Dental Insurance Market is segmented based on Coverage, Procedure, End-User, Industries, and Demographics.
  • Coverage, the market is classified into Dental Health Maintenance Organizations (DHMO), Dental Preferred Provider Organizations(DPPO), Dental Indemnity Plans, Dental Exclusive Provider Organisation (DEPO), Dental Point of Service (DPOS ).
  • Industries, the market is classified into Chemicals, Refineries, Metal and Mining, Food and Beverage, and Others.

Irwin Naturals Continues To Expand Clinic Footprint

Retrieved on: 
Tuesday, June 21, 2022
Population, Investor, CRNA, Agreement, National Action Alliance for Suicide Prevention, NAD, CEO, FRA, Company, OTC, Entrepreneurship, LLC, EBITDA, CBD, Preventive healthcare, CSE, Income, MSN, Interview, Acquisition, Cannabis, Philosophy, GLOBE, Life, Pharmaceutical industry, Online gambling, Invictus, Emergence

Klee Irwin, CEO, said, We are adding EBITDA to our bottom line with every clinic we bring into the fold.

Key Points: 
  • Klee Irwin, CEO, said, We are adding EBITDA to our bottom line with every clinic we bring into the fold.
  • In combining with Irwin Naturals, we become a part of a much larger, eventually national, footprint.
  • Irwin products are available in more than 100,000 stores in North America and Irwin Naturals is a brand known by 80 percent of U.S. households**.
  • *Under several corporate structures, Klee Irwin has operated the Irwin brand profitably since 1994, as measured by EBITDA adjusted for extraordinary costs.

AMERICAN COLLEGE OF PREVENTIVE MEDICINE ANNOUNCES SCIENTIFIC EXCELLENCE AWARD WINNERS

Retrieved on: 
Saturday, June 18, 2022
Fortis Healthcare, Public health, Hypertension, Science, Parental leave, Violence, Maternal health, Health equity, American College, Uniformed Services University of the Health Sciences, Research, Health promotion, American College of Preventive Medicine, Preventive healthcare, Physician, United States Armed Forces, Az-Zubair Prize for Innovation and Scientific Excellence, Health, Quality of life, Social media, FACPM, ACPM, MPH, DO, Multimedia, Tulane University, Health insurance, Pharmaceutical industry, Medical device, MD

DENVER, June 18, 2022 /PRNewswire/ -- On the closing day of Preventive Medicine 2022 (PM2022), the American College of Preventive Medicine (ACPM) announced the winners of its Scientific Excellence Awards for physician member-led, evidence-based research. ACPM President M. "Tonette" Krousel-Wood, MD, MSPH, FACPM, presented the awards during a ceremony at the annual meeting, which brings together the brightest minds in public health and preventive medicine.

Key Points: 
  • Posters focusing on health disparities, sex differences, maternal health and armed services hospitalizations honored during Preventive Medicine 2022 in Denver
    DENVER, June 18, 2022 /PRNewswire/ -- On the closing day of Preventive Medicine 2022 (PM2022), the American College of Preventive Medicine (ACPM) announced the winners of its Scientific Excellence Awards for physician member-led, evidence-based research.
  • ACPM President M. "Tonette" Krousel-Wood, MD, MSPH, FACPM, presented the awards during a ceremony at the annual meeting, which brings together the brightest minds in public health and preventive medicine.
  • The Scientific Excellence Awards are designed to recognize and reward the outstanding research of medical and scientific professionals working in preventive medicine.
  • More than 70 ACPM members showcased their latest research and shared best practices in preventive medicine during poster presentations at PM2022, and a panel consisting of members of the ACPM Board of Regents selected the top three honorees.

Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute

Retrieved on: 
Thursday, June 16, 2022
Industry, Public health, The New England Journal of Medicine, HIV/AIDS, Fortis Healthcare, Anal cancer, Risk, National Cancer Institute, Woman, Man, Cancer, Research, Subclinical infection, Adoption, UCSF, Biotechnology, USCF, Disease, Vaccination, MD, University, Health, Quality of life, AMC, HIV, History, Preventive healthcare, Incidence, Standard of care, Infection, Patient, University of California, San Francisco, Federation, Multimedia, Conference, Vulvar cancer, HSIL, HPV, Conference on Retroviruses and Opportunistic Infections, CRO, Anal, Pharmaceutical industry, Medicine, EMMS International

ROCKVILLE, Md., June 16, 2022 /PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that a team of its researchers contributed to a successful AIDS Malignancy Consortium (AMC) study. Results of the study, which demonstrated that treating and removing anal cancer precursor lesions reduced the cancer risk for HIV-infected men and women, were published in the New England Journal of Medicine. The Phase 3 trial results included 4,446 participants at 21 clinical sites across the U.S. and Puerto Rico.

Key Points: 
  • Results of the study , which demonstrated that treating and removing anal cancer precursor lesions reduced the cancer risk for HIV-infected men and women, were published in the New England Journal of Medicine.
  • The study enrolled people living with HIV aged 35 years and older who had at least one precursor lesion for anal cancer, called high-grade squamous intraepithelial lesions (HSIL).
  • According to Dr. Palefsky, "Anal cancer is the fourth most common cancer among people living with HIV.
  • For these individuals, the ANCHOR study shows for the first time that secondary prevention of anal cancer is possible through treatment of anal HSIL.

AMERICAN COLLEGE OF PREVENTIVE MEDICINE KICKS OFF PREVENTIVE MEDICINE 2022 CONFERENCE IN DENVER, CO

Retrieved on: 
Wednesday, June 15, 2022
Solution, Fortis Healthcare, Public health, Science, Vaccine hesitancy, CEO, Violence, Injury, Health equity, American College, Health, Research, Health promotion, American College of Preventive Medicine, Preventive healthcare, Physician, Quality of life, Social media, FACPM, Patient, Conditional sentence, ACPM, Pandemic, Multimedia, Population health, Pharmaceutical industry, MD

DENVER, June 15, 2022 /PRNewswire/ -- The American College of Preventive Medicine (ACPM) kicked off its annual meeting, Preventive Medicine 2022 (PM22), today in Denver, Colorado, bringing more than 400 members, guests and other leaders in preventive medicine together in person for the first time in two years. The conference, which will take place through Saturday, June 18, will focus on the science, evidence and analyses that inform preventive medicine practice.

Key Points: 
  • DENVER, June 15, 2022 /PRNewswire/ --The American College of Preventive Medicine (ACPM) kicked off its annual meeting, Preventive Medicine 2022 (PM22), today in Denver, Colorado, bringing more than 400 members, guests and other leaders in preventive medicine together in person for the first time in two years.
  • The conference, which will take place through Saturday, June 18, will focus on the science, evidence and analyses that inform preventive medicine practice.
  • ACPM's annual meeting brings together the brightest minds in public health and preventive medicine to share ideas on top issues impacting our nation's health.
  • "As we kick off PM2022, I look forward to sparking conversations about the important role preventive medicine physicians play in improving the health and wellbeing of our patients and communities," said Dr. M. 'Tonette' Krousel-Wood, MD, MSPH, FACPM, President of the American College of Preventive Medicine.

New Results Highlight Feasibility of Text Message Intervention to Encourage Dog-Facilitated Physical Activity

Retrieved on: 
Monday, June 13, 2022
Randomized controlled trial, Pediatrics, Caregiver, Parent, Text messaging, Research, Telethon Kids Institute, University of Western Australia, UWA, PAWS, Animal, BMC, Awareness, University, Outline, Preventive healthcare, Pediatric Research, Physical activity, MHealth, BioMed Central, Dog, Public health, Walking, Family, Screen time, Pharmaceutical industry, Hunting, Entertainment

WASHINGTON, June 13, 2022 /PRNewswire-PRWeb/ -- The Human Animal Bond Research Institute (HABRI) announced the results of a new publication led by researchers at the Telethon Kids Institute and The University of Western Australia (UWA), which found a simple health intervention using text messaging may encourage children to spend more time being physically active with their family dog. This randomized controlled trial was published in the journal BMC Pediatrics.

Key Points: 
  • "Interventions, policies, and community programs should capitalize on the high level of dog ownership and incorporate dog walking or play into physical activity campaigns."
  • "This study shows that a simple text message reminder to play or walk with the family dog can result in increased physical activity for children and their caregivers," said Steven Feldman, President of HABRI.
  • Dr. Christian and colleagues led the Play Spaces and Environments for Children's Physical Activity' (PLAYCE) PAWS mHealth intervention, a randomized controlled trial conducted in Perth, Western Australia.
  • A mobile health intervention to encourage physical activity in children: a randomised controlled trial.

Vilcek-Gold Award for Humanism in Healthcare Bestowed on Health Equity Leader Dr. Mona Fouad

Retrieved on: 
Wednesday, June 1, 2022
Foundation (nonprofit), Leadership, CEED, REACH, AAMC, Vilcek Foundation, Research, Jan Vilček, Health education, Medical school, Elimination, Empathy, Public health, CEO, Association of American Medical Colleges, Awareness, NIH, CDC, Humanism, Organization, National academy, University, Breast, UAB, GLOBE, Patient, Division, Preventive healthcare, National, Health, Risk, Gold, IRS, Association, History, National Academy of Medicine, MPH, Education, Office of Minority Health, Arnold, Medical device, Medicine, Management, Health care, Czechoslovakia, Medicine, MD

Dr. Fouad has been selected for the 2022 Vilcek-Gold Award for her leadership in health disparities research and for her career-long commitment to equity in healthcare.

Key Points: 
  • Dr. Fouad has been selected for the 2022 Vilcek-Gold Award for her leadership in health disparities research and for her career-long commitment to equity in healthcare.
  • In 1984, the couple moved to Birmingham, Alabama, where Dr. Fouad completed her Master of Public Health degree at the UAB.
  • We congratulate Dr. Fouad on her 2022 Vilcek-Gold Award, and we thank her for her great leadership in humanism in healthcare."
  • The Vilcek-Gold Award for Humanism in Healthcare includes an unrestricted cash prize of $10,000 and a commemorative heart-shaped trophy.

Global Health Leader and Physician, Dr. Seema Gupta Joins GATC Health Advisory Board

Retrieved on: 
Thursday, May 19, 2022
Department, Risk, Health, Education, Company, Global Health, Medicine, Marshall University, Cocaine, Preventive healthcare, Multimedia, Science, Clinical associates, Joan C. Edwards School of Medicine, View, Government, Artificial intelligence, Research, GATC, Opioid, Methamphetamine, Brain, PTSD, Time, Internal medicine, Editorial board, Post-traumatic stress disorder, Technology, Public health, Joan, Therapy, Coronavirus Scientific Advisory Board (Turkey), Private practice, Addiction, Human body, Drug discovery, Limbic system, Pharmaceutical industry

Dr. Gupta is a primary care physician with a federal government agency and has specific expertise in Internal Medicine, Preventive Medicine, Public Health, Global Health and Women/LGBT Health.

Key Points: 
  • Dr. Gupta is a primary care physician with a federal government agency and has specific expertise in Internal Medicine, Preventive Medicine, Public Health, Global Health and Women/LGBT Health.
  • Additionally, she serves on the Editorial Board of Internal Medicine Alerts, a leading scientific publication supporting evidence-based decision-making for medical providers.
  • "Dr. Gupta brings a broad range of expertise to GATC Health's Scientific Advisory Board," stated Dr Jonathan Lakey, Chief of the company's science advisory board.
  • "My goal is to bring to GATC Health the unique perspective of a practicing physician with years of experience," explained Dr. Gupta.

Global Liver Cancer Diagnostics Market Forecasts, 2021-2022 & 2028: Rising Emergence of New Technologies & Increasing Demand for Point-of-Care Testing - ResearchAndMarkets.com

Retrieved on: 
Friday, May 13, 2022
Health, Oncology, People, Diabetes, Colon, Breast, Risk, Centers for Disease Control and Prevention, HCC, Disease, Death, Non-alcoholic fatty liver disease, NASH, AME Publishing Company, Incidence, Liver, Endoscopy, Patient, Investment, Woman, IDF, Cirrhosis, Squamous cell carcinoma, Liver cancer, Hepatitis B, Obesity, Lists of diseases, Mortality, Overweight, Fatty liver disease, Research, Hepatoblastoma, Hepatocellular carcinoma, Smoking, Preventive healthcare, CRO, Type 2 diabetes, Man, Cholangiocarcinoma, Hospital, Biomarker, Biopsy, Lung, CDC, CAGR, NAFLD, Center, Growth, Prevalence, Cancer, Male, Laboratory, Hepatitis, Chronic liver disease, Dietary supplement, Medical imaging, Pharmaceutical industry, CCO

The growth of the liver cancer diagnostics market is primarily attributed to the rising prevalence of liver cancer and increasing R&D investments in the development of novel diagnostic testing.

Key Points: 
  • The growth of the liver cancer diagnostics market is primarily attributed to the rising prevalence of liver cancer and increasing R&D investments in the development of novel diagnostic testing.
  • On the other hand, the high cost of technologically advanced liver cancer diagnostic solutions hinders the growth of the market.
  • The factors mentioned above are increasing the chances of liver cancer, thereby driving the liver cancer diagnostics market.
  • The global liver cancer diagnostics market, based on type, is segmented into laboratory tests, endoscopy, imaging, biopsy, and others.

NEOGEN and FOXO Technologies Combine on Epigenetic Research Project

Retrieved on: 
Friday, April 29, 2022
Solution, Food safety, Medium (website), DNA, Intention, Associate, CEO, Harvard Medical School, Disease, Association, Physician, Brigham and Women's Hospital, Disinfectant, Illumina, Preventive healthcare, Division, Food, Animal testing, Cardiovascular disease, Ageing, MPH, Technology, Cancer, Risk, Plant, Animal, Longevity, Drug, Doctor of Science, Science, Heart, Wind Data Generator, Research, Hospital, Cone Health Women's Hospital, Mortality, NASDAQ, FOXO, Diabetes, Genomics, CLIA, Environment, Health, Dietary supplement, Pharmaceutical industry, Management, Brigham

LINCOLN, Neb., April 29, 2022 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) and FOXO Technologies, Inc. ("FOXO") — a technology company applying epigenetic science and AI to modernize the life insurance industry — collaborated on an extensive research project examining the association between epigenetic aging and numerous behavioral, lifestyle, dietary and clinical risk factors, as well as major morbidity and mortality outcomes.

Key Points: 
  • LINCOLN, Neb., April 29, 2022 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) and FOXO Technologies, Inc. ("FOXO") a technology company applying epigenetic science and AI to modernize the life insurance industry collaborated on an extensive research project examining the association between epigenetic aging and numerous behavioral, lifestyle, dietary and clinical risk factors, as well as major morbidity and mortality outcomes.
  • The data was then sent to FOXO for high throughput bioinformatic processing and epigenetic analysis.
  • "NEOGEN and our genomics team are pleased to be a part of such an important project," says John Adent, NEOGEN's President and CEO.
  • "This research project has been a very exciting undertaking for both FOXO and NEOGEN," said Brian Chen, Ph.D., Chief Science Officer at FOXO.